Arkolith/Insider Trading/FDMT/Form 4

Bizily Scott

Chief Legal Officer4D Molecular Therapeutics, Inc. (FDMT) · full profile →Form 4 · filed Jun 20, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$41K
Net Open-Market Flow
-$41K
Transactions
5
3 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 17, 2024Sell(S)2K$23.71$41K2K
Jun 17, 2024Option exercise(M)500$6.49$3K2K
Jun 17, 2024Option exercise(M)1K$8.04$10K3K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 17, 2024Option exercise(M)500—$013K
Jun 17, 2024Option exercise(M)1K—$037K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-075692) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML